Dr. Leonard is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3181 Sw Sam Jackson Park Rd
Ohsu
Portland, OR 97239Phone+1 503-494-8211- Is this information wrong?
Education & Training
Oregon Health & Science UniversityFellowship, Hematology and Medical Oncology, 2013 - 2016- Oregon Health & Science UniversityResidency, Internal Medicine, 2010 - 2013
Northeast Ohio Medical UniversityClass of 2010
Certifications & Licensure
OR State Medical License 2012 - 2025
WA State Medical License 1999 - 2011- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Venetoclax, Dasatinib, Prednisone, Rituximab and Blinatumomab for the Treatment of Newly Diagnosed or Relapsed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia or Mixed Phenotype Acute Leukemia Start of enrollment: 2022 Sep 02
- A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia Start of enrollment: 2018 Oct 04
Roles: Principal Investigator
- XmAb18968 (CD3-CD38) in Relapsed or Refractory Acute Leukemia and T Cell Lymphoblastic Leukemia Start of enrollment: 2022 Feb 02
Roles: Contact
Publications & Presentations
PubMed
- Novel Biomarkers and Molecular Targets in ALL.De Sa, H., Leonard, J.> ;Current Hematologic Malignancy Reports. 2024 Feb 1
- 7 citationsNext-generation sequencing-based MRD in adults with ALL undergoing hematopoietic cell transplantation.Emily C Liang, Simone E Dekker, Jean M G Sabile, Stefan Torelli, Amy Zhang, Katharine Miller, Parveen Shiraz, Brandon Hayes-Lattin, Jessica T Leonard, Lori Muffly> ;Blood Advances. 2023 Jul 25
- 6 citationsUsing Measurable Residual Disease to Optimize Management of AML, ALL, and Chronic Myeloid Leukemia.Simone E Dekker, Delphine Rea, Jean-Michel Cayuela, Isabell Arnhardt, Jessica Leonard, Michael Heuser> ;American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2023 Jun 1
- Join now to see all
Abstracts/Posters
- Simultaneous Kinase Inhibition with Ibrutinib and BCL2 Inhibition with Venetoclax As a Therapeutic Strategy for Acute Lymphoblastic LeukemiaJessica Leonard, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Safety and Efficacy of Venetoclax in Combination with Navitoclax in Adult and Pediatric Relapsed/Refractory Acute Lymphoblastic Leukemia and Lymphoblastic LymphomaJessica Leonard, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Press Mentions
County Increasing Testing Access, Warns of 'Overburdened' HospitalsDecember 9th, 2021
Hospital Affiliations
OHSU HospitalPortland, Oregon
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
